BARBARACI, CARLA
 Distribuzione geografica
Continente #
EU - Europa 227
NA - Nord America 178
AF - Africa 75
AS - Asia 33
OC - Oceania 1
Totale 514
Nazione #
US - Stati Uniti d'America 173
IT - Italia 154
CI - Costa d'Avorio 53
IE - Irlanda 31
CN - Cina 21
SN - Senegal 20
DE - Germania 14
RU - Federazione Russa 7
CA - Canada 5
ES - Italia 4
FR - Francia 4
GB - Regno Unito 4
VN - Vietnam 4
SG - Singapore 3
HK - Hong Kong 2
NG - Nigeria 2
NL - Olanda 2
UA - Ucraina 2
UZ - Uzbekistan 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
HU - Ungheria 1
IN - India 1
SE - Svezia 1
Totale 514
Città #
Chandler 78
Abidjan 53
Catania 35
Dublin 30
Dakar 20
Ashburn 11
Palermo 9
Andover 8
Cambridge 8
Lawrence 8
Milan 7
Bremen 6
Nanjing 6
Des Moines 5
Raffadali 5
Rome 4
Toronto 4
Acireale 3
Bari 3
Casagiove 3
New York 3
Padova 3
Randazzo 3
Abuja 2
Beijing 2
Cagliari 2
Dong Ket 2
Hanoi 2
Hebei 2
Hong Kong 2
Los Angeles 2
Marano Principato 2
Marsala 2
Messina 2
Moscow 2
Naples 2
San Giovanni la Punta 2
Shenyang 2
Terrassa 2
Wilmington 2
Alcamo 1
Amsterdam 1
Augusta 1
Boardman 1
Bronte 1
Budapest 1
Canberra 1
Castelvetrano 1
Dearborn 1
Den Haag 1
Desio 1
Edinburgh 1
Florence 1
Foggia 1
Giarre 1
Greystones 1
Houston 1
Jacksonville 1
Jinan 1
Lappeenranta 1
Leawood 1
Ludwigshafen 1
Madrid 1
Mascalucia 1
Mazara Del Vallo 1
Nanchang 1
Ottawa 1
Paris 1
Parkersburg 1
Piedimonte Etneo 1
Pozzo Di Gotto 1
Pune 1
Redwood City 1
Rimini 1
Saint Petersburg 1
San Francisco 1
Scafati 1
Scicli 1
Valencia 1
Zhengzhou 1
Totale 389
Nome #
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 92
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 65
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 57
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 51
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 48
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 47
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 45
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 35
Interaction of new sigma ligands with biomembrane models evaluated by differential scanning calorimetry and Langmuir-Blodgett studies 28
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 21
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 17
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment 17
Ligandi ibridi Sigma-HDAC come potenziale trattamento terapeutico per il melanoma uveale: design, sintesi e valutazione biologica 9
Preliminary in vitro and in vivo studies of (S)-(–)-MRJF22 loaded-NLC for potential treatment of uveal melanoma 6
NLC for the delivery of new prodrugs in the treatment of uveal melanoma 5
Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma 5
Haloperidol metabolite II Valproate ester-loaded NLC as promising strategy for the treatment of Uveal Melanoma 4
NLC as promising platform to deliver new prodrugs in the treatment of ophthalmic cancer 3
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 3
DESIGN, SYNTHESIS, MOLECULAR MODELING AND PHARMACOLOGICAL EVALUATION OF NOVEL DIAZABICYCLO[4.3.0]NONANE AND 2,7-DIAZASPIRO[3.5]NONANE AS SIGMA RECEPTORS LIGANDS 2
Totale 560
Categoria #
all - tutte 2.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/202031 9 3 0 3 1 2 2 2 0 3 5 1
2020/202125 0 0 4 5 6 1 1 0 0 2 2 4
2021/202297 2 8 4 1 15 2 13 5 15 8 0 24
2022/2023220 21 21 4 28 9 37 0 48 31 3 15 3
2023/2024149 7 30 5 15 10 46 17 12 3 4 0 0
Totale 560